Kolexia
Chouaid Christos Santé publique
Chouaid Christos
Santé publique
Centre Hospitalier Intercommunal Créteil
Créteil, France
701 Activités
7 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Broncho-pneumopathie chronique obstructive Métastase tumorale Maladies pulmonaires Récidive tumorale locale Adénocarcinome Tumeurs du cerveau

Collaborateurs

Voir plus
Monnet Isabelle
Monnet Isabelle
Centre Hospitalier Intercommunal Créteil, Créteil, France
Vergnenegre Alain
Vergnenegre Alain
Hôpital Dupuytren, Limoges, France
Perol Maurice
Perol Maurice
Centre Léon-Bérard, Lyon, France
Auliac Jean-Bernard
Auliac Jean-Bernard
Centre Hospitalier Intercommunal Créteil, Créteil, France

Industries

Voir plus
AstraZeneca
76 collaboration(s)
Dernière en 2023
MSD
42 collaboration(s)
Dernière en 2023
BMS
41 collaboration(s)
Dernière en 2023
Amgen
34 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Resected -mutated non-small-cell lung cancers: incidence and outcomes in a European population (GFPC Exerpos Study).
Therapeutic advances in medical oncology   06 mars 2024
Plasma Tissue Factor Activity in lung cancer patients predicts venous thrombo-embolism and poor overall survival
Research and practice in thrombosis and haemostasis   01 mars 2024
MELROSE: Phase 2 Study Evaluating MEchanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtinib Until and Beyond Radiological Progression : the MELROSE Trial
Essai Clinique (AstraZeneca)   26 février 2024
Lung cancer, comorbidities, and medication: the infernal trio.
Frontiers in pharmacology   21 février 2024
Pan Tumor Nivolumab Rollover Study: Pan-Tumor Study for Long Term Follow-up of Cancer Survivors Who Have Participated in Trials Investigating Nivolumab
Essai Clinique (BMS)   14 février 2024
Disentangling the reasons why older adults do not readily participate in cancer trials: a socio-epidemiological mixed methods approach.
Age and ageing   14 février 2024
Impact of the COVID-19 Pandemic on COPD Patient Mortality: A Nationwide Study in France.
International journal of public health   01 février 2024
Clinical benefit of anti-PD-1/PD-L1 plus chemotherapy in first-line treatment for patients over the age of 65 or 75 with metastatic non-small cell lung cancer (NSCLC).
Journal of chemotherapy (Florence, Italy)   01 février 2024
BREC: Multicenter Phase III, Randomized Study to Evaluate Treatment Customized According to RAP80 and BRCA1 Assessment in Patients With Advanced Non-small-cell Lung Cancer
Essai Clinique (Spanish Lung Cancer Group)   29 janvier 2024
First Real-world Data on Unresectable Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy
Essai Clinique (AstraZeneca)   19 janvier 2024